Regulus Therapeutics (RGLS) - Cost to borrow shares

Latest borrow fee for Regulus Therapeutics (RGLS) shares on Interactive Brokers: 8.1326% (annualized)

Shares available to borrow: 1000000
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Regulus Therapeutics (RGLS) - cost to borrow in the last 7 days chart

Regulus Therapeutics (RGLS) - number of shares available to borrow in the last 7 days

Regulus Therapeutics (RGLS) - cost to borrow from 2024 to 2023

Regulus Therapeutics (RGLS) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company	Cost to borrow (% year)	Shares available	Country
GlaxoSmithKline GSK	0.4802%	1.4 M	🇬🇧 UK
Sanofi SNY	0.517%	1.6 M	🇫🇷 France
Biogen BIIB	0.25%	3.9 M	🇺🇸 USA
AstraZeneca AZN	0.25%	10 M	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	0.3528%	2.2 M	🇺🇸 USA
Sangamo Therapeutics SGMO	0.4401%	1 M	🇺🇸 USA
Bristol-Myers Squibb BMY	0.25%	10 M	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions